-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704.O2.6 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Novel Approaches to Enhance Cellular Therapies and Immune Responses in Leukemias and Lymphomas

Symposia: Cellular Immunotherapies: Early Phase and Investigational Therapies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, ALL, Hodgkin lymphoma, Lymphoid Leukemias, Acute Myeloid Malignancies, AML, Biological therapies, Translational Research, Lymphomas, Bispecific Antibody Therapy, Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Therapies, Immunotherapy, therapy sequence, Lymphoid Malignancies, Myeloid Malignancies, Natural Killer (NK) Cell Therapies, Transplantation, Vaccines
Monday, December 11, 2023: 10:30 AM-12:00 PM
Room 6CF (San Diego Convention Center)
Moderators:
Paolo Strati, MD, MD Anderson Cancer Center and John C Molina, MD, MEd, Taussig Cancer Institute, Cleveland Clinic Foundation
Disclosures:
Molina: Autolus: Consultancy, Honoraria.
10:30 AM

Arjan A. van de Loosdrecht, MD, PhD1, Eva Wagner Drouet, MD2*, Uwe Platzbecker, MD3, Tobias A.W. Holderried, MD4*, Catharina Van Elssen, MD, PhD5*, Aristoteles Giagounidis6, Soren Lehmann, MD, PhD7*, Hester Van Zeeburg8*, Jeroen Rovers, MD, PhD9* and Bjorn T. Gjertsen, MD, PhD10

1Department of Hematology, Amsterdam UMC, location VUmc, CCA, Amsterdam, Netherlands
2Universitätsmedizin der Johannes Gutenberg-Universität, Mainz, Germany
3Department of Hematology, University Hospital of Leipzig, Leipzig, Germany
4Universitaetsklinikum Bonn (UKB), Bonn, Germany
5Maastricht University Medical Centre, Maastricht, Netherlands
6Dept. Oncology, Hematology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
7Department of Medical Sciences, Hematology, Uppsala University, University Hospital Uppsala, Uppsala, Sweden
8Mendus AB, Leiden, Netherlands
9Mendus AB, Leiden, Sweden
10Department of Medicine, Haematology section, Haukeland Universitetssykehus, Bergen, Norway

10:45 AM

Armin Ghobadi, MD1, Ibrahim Aldoss, MD2, Shannon L. Maude, MD3, Deepa Bhojwani, MD4, Alan S. Wayne, MD4, Ashish Bajel, FRACP5, Rawan Faramand, MD6, Ryan J Mattison, MD7, Bhagirathbhai Dholaria, MBBS8, Michael P. Rettig, PhD9,10, Ken Jacobs, MD11*, Ouiam Bakkacha12*, John Muth, MSc13*, Angela Pannunzio14*, Brett Ramsey, MBA12*, Eileen McNulty, MS15*, Matt L. Cooper, PhD16, Jan Davidson-Moncada, MD, PhD, MSc17 and John F. DiPersio, MD, PhD10

1Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2City of Hope, Duarte, CA
3The Children's Hospital of Philadelphia, Philadelphia, PA
4Children's Hospital of Los Angeles, Los Angeles, CA
5Clinical Haematology, Royal Melbourne Hospital, Parkville, Vic, Australia
6Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
7Carbone Comprehensive Cancer Center, Madison, WI
8Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
9Washington Univ. School of Med., Saint Louis, MO
10Washington University School of Medicine, Saint Louis, MO
11Wugen, St louis, MO
12Wugen, Saint Louis, MO
13Wugen, St. Louis, MO
14Wugen, St Louis
15Wugen, St Louis, MO
16Wugen Inc., Saint Louis, MO
17Wugen, Washington, DC

11:00 AM

Nirali N. Shah, M.D.1, Sarah K Tasian, MD2, M. Eric Kohler, MD, PhD3, Emily M. Hsieh, MD4, Susanne H.C. Baumeister, MD5, Corinne Summers, MD6*, Haneen Shalabi, DO7, Jessica A. Pollard, MD8, Bonnie Yates, NP9*, Ruta Brazauskas, PhD10*, Eric Ndifon11*, Constance M. Yuan, MD, PhD12*, Hao-Wei Wang, MD, PhD12*, Hati K Kobusingye13*, Kayla Christianson13*, Allison A Weiss13*, Erin Leckrone13*, Bronwen E. Shaw, PhD, MRCP, FRCPath14, Jeffery J. Auletta, MD15, Hemalatha G. Rangarajan, MD16, John Roach17*, Julie Blake18*, Dennis Michiel19*, Brian Bowser17*, Sheryl Ruppel17*, George Mitra20*, Anthony Welch21*, Jason Yovandich22*, Rachelle Salomon21*, Leslie Kean23, Katherine Tarlock, MD24, Michael A. Pulsipher, MD25, Michael R Verneris, MD26, Larisa Broglie, MD27, Terry J. Fry, MD28, Steven M. Devine, MD29 and Richard Aplenc, MD, PhD30

1Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Children's Hospital of Philadelphia, Philadelphia, PA
3Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado School of Medicine, Aurora, CO
4Children's Hospital Los Angeles, Los Angeles, CA
5Division of Pediatric Oncology, Dana Farber Cancer Inst./Children's Hospital Boston, Boston, MA
6Seattle Children's Hospital, Seattle, WA
7Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA, Bethesda, MD
8Dana Farber Cancer Institute/Boston Children's Hospital, Boston, MA
9Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
10Division of Biostatistics, Medical College of Wisconsin, Milwaukee
11CIBMTR, National Marrow Donor Program, CIBMTR, Minneapolis
12Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
13National Marrow Donor Program, Minneapolis
14CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee
15CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
16Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Childrens Hospital, Columbus, OH
17NCI, Biopharmaceutical Development Program, Frederick National Laboratory for Cancer Research, Frederick
18Biopharmaceutical Development Program, Frederick National Laboratory for Cancer Research, Frederick, MD
19NCI, michield@mail.nih.gov, Frederick
20Biopharmaceutical Development Program, Frederick National Laboratory for Cancer Research, Frederick
21Biological Resources Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick
22NIH/NCI, Frederick, MD
23Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
24Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
25Huntsman Cancer Institute, Salt Lake City, UT
26Children's Hospital Colorado, University of Colorado At Denver, Aurora, CO
27CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine,, Medical College of Wisconsin, Fox Point, WI
28University of Colorado Anschutz Medical Campus, Aurora, CO
29Be the Match Foundation, Minneapolis, MN
30Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA

11:15 AM

Jessica Liegel, MD1, Giulia Cheloni, PhD1*, Georges Chedid, MD1*, Genevieve Gerhard, MD1*, Dimitra Karagkouni1*, Richard Stone2, Robert J. Soiffer, MD2, Lina Bisharat1*, Samprity Ankita1*, Isabella Saldarriaga1*, Emma K Logan1*, Michele Narcis1*, Jennifer Tichon1*, Yiwen Liu, MS2*, Malgorzata McMasters, MD3, Juan Carlos Varela, MD, PhD1*, Hassan El Banna2*, Vincent T. Ho, MD2*, Rizwan Romee, MD2, Donna S. Neuberg, ScD2, Kathrine S Rallis, MBBS, MSc4, Sophia Adamia, PhD1, Benjamin L. Ebert, MD, PhD2, Donald Kufe, MD2*, Ioannis Vlachos, PhD1*, David Avigan, MD1 and Jacalyn Rosenblatt, MD1

1Beth Israel Deaconess Medical Center, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Massachusetts General Hospital, Boston, MA
4Beth Israel Deaconess Medical Center, Brookline, MA

11:30 AM

Samer A. Srour, MD1, Amandeep Salhotra, MD2, Robert Lowsky, MD3*, Rasmus T. Hoeg, MD4*, Edmund K. Waller, MD5, Anna Pavlova, MD, PhD6, J. Scott McClellan, MD, PhD7, Nathaniel B. Fernhoff, PhD7*, Everett H. Meyer, MD, PhD8 and Mehrdad Abedi, MD9*

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
3Stanford Univ. Med. Ctr., Stanford, CA
4Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis, Sacramento, CA
5Winship Cancer Institute, Emory University, Atlanta, GA
6Orcabio, Menlo Park, CA
7Orca Bio, Menlo Park, CA
8Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Medical Center, Stanford, CA
9Comprehensive Cancer Center, University of California, Davis, Sacramento, CA

11:45 AM

Yago Nieto, MD, PhD1, Pinaki Banerjee, PhD2*, Indreshpal Kaur, PhD2*, Lori Griffin2*, Melissa Barnett2*, Christina Ganesh2*, Zephanie Borneo2*, Roland L. Bassett, MS3*, Lucila Nassif Kerbauy, MD, PhD2, Rafet Basar, MD2*, Mecit Kaplan2, Daniel Esqueda2*, Jeremy Ramdial, MD2, Sairah Ahmed, MD4, Chitra Hosing, MD2, Samer A. Srour, MD2, Amin Alousi2*, Muzaffar H. Qazilbash, MD2, Raphael Eric Steiner, MD5, Karenza Alexis6*, Michael Emig, MD7*, Andreas Harstrick7*, Elizabeth J. Shpall, MD2 and Katy Rezvani, MD8

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
6Affimed Inc., Heidelberg, Germany
7Affimed GmbH, Heidelberg, Germany
8Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX

*signifies non-member of ASH